Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility
about
Opioid-induced constipation: advances and clinical guidanceRecent Updates on the Treatment of ConstipationE-type prostanoid receptor 4 (EP4) in disease and therapyClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetLuminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents.Lubiprostone stimulates small intestinal mucin release.Lubiprostone in constipation: clinical evidence and place in therapy.Localization and vasopressin regulation of the Na⁺-K⁺-2Cl⁻ cotransporter in the distal colonic epithelium.Advancing treatment options for chronic idiopathic constipation.Cell-specific effects of luminal acid, bicarbonate, cAMP, and carbachol on transporter trafficking in the intestineCharacterization of CFTR High Expresser cells in the intestine.Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.Management of constipation in Parkinson's disease.Impaired viscosity of gastric secretion and its mucin content as potential contributing factors to the development of chronic constipation.Carbachol-induced colonic mucus formation requires transport via NKCC1, K⁺ channels and CFTR.Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.Pharmaceutical Activation or Genetic Absence of ClC-2 Alters Tight Junctions During Experimental Colitis.Impaired PGE2-stimulated Cl- and HCO3- secretion contributes to cystic fibrosis airway disease.ClC-2 and intestinal chloride secretion.
P2860
Q26765571-FCBDF9A7-C27A-4D4A-9AAD-BB11397DB592Q26820242-1EFD1D06-959D-4C3C-833E-C7CA90FEEDDEQ26851156-4A2132DC-EBCA-4126-9410-10C1768F488EQ28066092-6C194303-6938-4D06-9D86-82089165ACCEQ33854983-D1A01803-8584-4EB7-BC42-B46EBAFB109AQ34468167-619A9075-7AB9-4276-BD15-F952AF8EE034Q35091370-9E384BB4-E925-49F0-A37E-3E1279AC5E6CQ35159966-22FAC19B-4749-4477-BB5F-801F8CA6A826Q35858864-5C9EA563-1309-4D64-BD36-E3C3949EC6F0Q36312701-5CEE4E4A-E984-4AB3-83C0-1CE868E91E60Q37142584-CF7B6447-3A0C-4F87-92A0-5F7F37DA846BQ37491434-B719F7E3-91B2-49A4-A875-053FEA906CA1Q38175457-56E935F0-6760-4BE7-A9C8-CF7E6F70A3FEQ38300388-294D7121-7B87-4A0A-A3B7-1522A152DC20Q40197855-AFBEFC21-7A5C-434A-A799-F9470EF4E471Q41813130-4B21DD1A-B621-427F-B553-7AC22A4F43F6Q42494201-F2DBB162-B299-44EE-A025-7561D206C6BAQ44859490-872605DA-742B-4E46-9EE9-0CE7B02ABC70Q48342278-013F40B9-9FAD-4CE9-AF44-6EB6B21F49CBQ51335923-034A8D56-1D35-48FD-8BA5-B331278C9555
P2860
Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lubiprostone targets prostanoi ...... exocytosis, and contractility
@en
type
label
Lubiprostone targets prostanoi ...... exocytosis, and contractility
@en
prefLabel
Lubiprostone targets prostanoi ...... exocytosis, and contractility
@en
P2093
P2860
P1476
Lubiprostone targets prostanoi ...... exocytosis, and contractility
@en
P2093
Anne M Collaco
Nadia A Ameen
Robert L Jakab
P2860
P2888
P304
P356
10.1007/S10620-012-2352-8
P577
2012-08-25T00:00:00Z